| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/14/1998 | CN1036993C Method for preparation aromatase inhigiting 4(5)-imidazoles |
| 01/13/1998 | US5708173 Heterocyclic compounds |
| 01/13/1998 | US5708171 Imidazole derivatives for pharmaceutical use |
| 01/13/1998 | US5708164 Cephalostatin analogues |
| 01/13/1998 | US5708163 Synthesis of the breast tumor-associated antigen defined by monoclonalantibody MBRL and uses thereof |
| 01/13/1998 | US5708157 Secreted proteins and polynucleotides encoding them |
| 01/13/1998 | US5708146 Antibodies and drugs |
| 01/13/1998 | US5708034 Substituted sulfonimidamides, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them |
| 01/13/1998 | US5708025 By inducing production of fetal hemoglobins by administering specified aryl acids, derivatives, salts |
| 01/13/1998 | US5708020 Arylalkyl(thio)amides |
| 01/13/1998 | US5707992 Microbiocides, antitumor agents |
| 01/13/1998 | US5707989 Pyrimido 5,4-D!pyrimidines, medicaments comprising these compounds, their use and processes for their preparation |
| 01/13/1998 | US5707978 Antitumor agents, psoriasis, antiinflammatory agents |
| 01/13/1998 | US5707863 Tumor suppressor gene merlin |
| 01/13/1998 | US5707829 DNA sequences and secreted proteins encoded thereby |
| 01/13/1998 | US5707815 Polypeptides produced bby expression of heterologous nucleic acid in cells and encoded by dna and hybridize |
| 01/13/1998 | US5707795 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
| 01/13/1998 | US5707632 Immunology |
| 01/12/1998 | CA2210056A1 Cyclic sulfone derivatives |
| 01/10/1998 | CA2208676A1 Mercaptoketones and mercaptoalcohols and a process for their preparation |
| 01/10/1998 | CA2206997A1 Benzothiophene compounds and methods of use |
| 01/08/1998 | WO1998000439A2 Multivalent compounds for cross-linking receptors and uses thereof |
| 01/08/1998 | WO1998000431A1 New salts of anionic complexes of ru(iii), as antimetastatic and antineoplastic agents |
| 01/08/1998 | WO1998000411A1 Prenyl transferase inhibitors |
| 01/08/1998 | WO1998000409A1 Inhibitors of prenyl transferases |
| 01/08/1998 | WO1998000404A1 Anthranilic acid diamides derivatives, their preparation and pharmaceutical use as anti-gastrin agents |
| 01/08/1998 | WO1998000402A1 Piperazine derivatives and process for the preparation thereof |
| 01/08/1998 | WO1998000395A1 Phenylalamine derivatives as integrin inhibitors |
| 01/08/1998 | WO1998000173A2 Targeted drug delivery using sulfonamide derivatives |
| 01/08/1998 | WO1998000163A1 INDUCTION OF CTLs SPECIFIC FOR NATURAL ANTIGENS BY CROSS-PRIMING IMMUNIZATION |
| 01/08/1998 | WO1998000158A1 Non-aqueous polar aprotic peptide formulations |
| 01/08/1998 | WO1998000157A1 Aqueous formulations of peptides |
| 01/08/1998 | WO1998000152A1 Non-aqueous protic peptide formulations |
| 01/08/1998 | WO1998000127A1 Retinoyloxy(substituted)alkylene butyrates useful for the treatment of cancer and other proliferative diseases |
| 01/08/1998 | WO1997041824A3 Antiangiogenic peptides derived from plasminogen |
| 01/08/1998 | WO1997033995A3 Extracellular matrix signalling molecules |
| 01/08/1998 | WO1997031936A3 Novel ortho-naphthoquinone derivatives, novel synthesis therefor, and their use in the inhibition of neoplastic cell growth |
| 01/08/1998 | DE19627376A1 Verwendung von Artischocken-(Cynara)-Extrakten Use of artichoke (Cynara) extracts |
| 01/08/1998 | DE19627164A1 Herstellung Polyether-aufweisender Chlorine und Bakteriochlorine Producing polyether having Direction Chlorine and bacteriochlorins |
| 01/08/1998 | DE19624704A1 Neue Pyridylalkansäureamide New Pyridylalkansäureamide |
| 01/08/1998 | DE19624659A1 Neue Pyridylalken- und Pyridylalkinsäureamide New pyridylalkene and pyridylalkine acid |
| 01/08/1998 | DE19624154A1 Ringannelierte Dihydropyrane, Verfahren zur Herstellung sowie deren Verwendung Ring Anne lined dihydropyrans, methods of preparation and their use |
| 01/08/1998 | CA2259557A1 Non-aqueous polar aprotic peptide formulations |
| 01/08/1998 | CA2259505A1 Aqueous formulations of peptides |
| 01/08/1998 | CA2259403A1 Non-aqueous protic peptide formulations |
| 01/08/1998 | CA2259224A1 Phenylalamine derivatives as integrin inhibitors |
| 01/08/1998 | CA2258840A1 Induction of ctls specific for natural antigens by cross-priming immunization |
| 01/08/1998 | CA2258593A1 Retinoyloxy(substituted)alkylene butyrates useful for the treatment of cancer and other proliferative diseases |
| 01/08/1998 | CA2258038A1 Multivalent compounds for cross-linking receptors and uses thereof |
| 01/08/1998 | CA2255893A1 Prenyl transferase inhibitors |
| 01/08/1998 | CA2205554A1 Novel isoform gene for focal adhesion protein paxillin |
| 01/07/1998 | EP0816497A2 Human requiem polypeptide for apoptosis |
| 01/07/1998 | EP0816496A2 T-cells specific for kidney carcinoma |
| 01/07/1998 | EP0816360A1 Benzothiophene compounds, intermediates, processes, and methods of use |
| 01/07/1998 | EP0815446A1 Method of identifying molecules that regulate fgf activity |
| 01/07/1998 | EP0815245A1 Bioactive fusion proteins and pre-existing tumor therapy |
| 01/07/1998 | EP0815240A1 Novel human cyclin-dependent kinase-like proteins and methods of using the same |
| 01/07/1998 | EP0815229A2 Rage tumor rejection antigens |
| 01/07/1998 | EP0815228A2 Cellubrevin homologs |
| 01/07/1998 | EP0815221A1 A novel growth factor and a genetic sequence encoding same |
| 01/07/1998 | EP0815218A2 Human vegf-specific antisense oligonucleotides |
| 01/07/1998 | EP0815216A2 Antisense transcript expressed in b lymphocytes and synthetic oligonucleotides useful to inhibit the activity thereof |
| 01/07/1998 | EP0815215A2 An antisense transcript associated to tumor cells having a t(14;18) translocation and oligodeoxynucleotides useful in the diagnosis and treatment of said tumor cells |
| 01/07/1998 | EP0815204A1 Method for treating tumors |
| 01/07/1998 | EP0815127A1 Fucopeptides |
| 01/07/1998 | EP0815126A1 Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical composition |
| 01/07/1998 | EP0815120A1 17-difluoromethylene-oestratrienes |
| 01/07/1998 | EP0815118A1 ISOLATED NUCLEIC ACID MOLECULES WHICH ARE MEMBERS OF THE MAGE-Xp FAMILY AND USES THEREOF |
| 01/07/1998 | EP0815116A1 Inhibition and modulation of gonadotropin-releasing hormone receptor activity |
| 01/07/1998 | EP0815115A1 Keratinocyte growth factor-2 |
| 01/07/1998 | EP0815113A1 Water-soluble esters of camptothecin compounds |
| 01/07/1998 | EP0815111A1 Analogues of n-acetylardeemin, method of preparation and uses thereof |
| 01/07/1998 | EP0815103A1 Trypsin and thrombin inhibitors |
| 01/07/1998 | EP0815100A1 Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 01/07/1998 | EP0815099A1 Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 01/07/1998 | EP0815096A1 Cephalomannine epoxide, its analogues and a method for preparing the same |
| 01/07/1998 | EP0815095A1 10-DEACETYLBACCATINE III AND 10-DEACETYL 14$g(b)-HYDROXYBACCATINE III DERIVATIVES, A PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| 01/07/1998 | EP0815087A1 Trisubstituted phenyl derivatives |
| 01/07/1998 | EP0815084A1 Lactam-containing hydroxamic acid derivatives, their preparation and their use as inhibitors of matrix metalloprotease |
| 01/07/1998 | EP0815081A1 Piperidinyl-2-alkyl subst. linear polyamines for the reduction of intracellular, endogenic polyamine levels such as putrescine, spermidine and spermine, and their impact on cell proliferation |
| 01/07/1998 | EP0814838A1 Antigen presenting system and methods for activation of t-cells |
| 01/07/1998 | EP0814827A1 Vascular endothelial growth factor-b |
| 01/07/1998 | EP0814823A1 Polyphenol fractions of tea, the use thereof and formulations containing them |
| 01/07/1998 | EP0814821A1 Immunomodulating compositions from bile for the treatment of immune system disorders |
| 01/07/1998 | EP0814813A2 Use of penciclovir for the treatment of human herpes-virus-8 |
| 01/07/1998 | EP0814808A1 Pharmaceutical, cosmetic and/or food composition having anti-oxidant properties |
| 01/07/1998 | EP0814807A1 Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 01/07/1998 | EP0814795A2 Use of betulinic acid and its derivatives for inhibiting malignant melanoma growth and a method of monitoring this |
| 01/07/1998 | EP0814792A1 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase |
| 01/07/1998 | EP0814784A1 Use of ketorolac for treatment of squamous cell carcinomas of the oral cavity or oropharynx |
| 01/07/1998 | EP0700301A4 Peptides and compounds that bind to elam-1 |
| 01/07/1998 | EP0464175B1 Extracellular form of the human fibroblast growth factor receptor |
| 01/07/1998 | CN1169778A Detection and treatment of cancer |
| 01/07/1998 | CN1169729A Modulators functions of FAS/APOL receptors |
| 01/07/1998 | CN1169726A 6-aryl pyrido (2,3-d) pyrimidines and naphthyridines for inhibiting protein tyrosine kinase medicated cellular proliferation |
| 01/07/1998 | CN1169425A Fluorinated vitamin D3 analogs |
| 01/07/1998 | CN1036920C Heterocycle-containing carbonic acid derivatives |
| 01/06/1998 | US5705625 Genetic engineering; medical diagnosis |
| 01/06/1998 | US5705615 Antibodies specific for HTm4 |
| 01/06/1998 | US5705528 Farnesyl derivatives and pharmaceutical compositions containing them |